Cochlear (Cochlear) Inventories, Finished Goods : $0 Mil (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Cochlear Inventories, Finished Goods?

Cochlear's quarterly finished goods increased from Dec. 2022 ($0 Mil) to Jun. 2023 ($99 Mil) but then declined from Jun. 2023 ($99 Mil) to Dec. 2023 ($0 Mil).

Cochlear's annual finished goods increased from Jun. 2021 ($73 Mil) to Jun. 2022 ($102 Mil) but then declined from Jun. 2022 ($102 Mil) to Jun. 2023 ($99 Mil).

Cochlear Inventories, Finished Goods Historical Data

The historical data trend for Cochlear's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cochlear Inventories, Finished Goods Chart

Cochlear Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Inventories, Finished Goods

Get a 7-Day Free Trial

68.68

75.02

73.24

101.97

99.06

Cochlear Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Inventories, Finished Goods	Get a 7-Day Free Trial															-	101.97	-	99.06	-

Cochlear Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Cochlear (Cochlear) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cochlear Ltd (OTCPK:CHEOF) » Definitions » Inventories, Finished Goods

Comparable Companies

Traded in Other Exchanges

CHEOY:USA OC5:Germany COH:Australia

Address

1 University Avenue, Macquarie University, Sydney, NSW, AUS, 2109

Website

https://www.cochlear.com

Cochlear is the leading cochlear implant device manufacturer with around 60% global market share. Developed markets contribute 80% of group revenue where cochlear implants are the standard of care for children with severe to profound hearing loss. The company also actively targets the growing cohort of seniors in developed markets. Tender-oriented emerging markets contribute the remaining 20% of group revenue. Main products include cochlear implants, bone-anchored hearing aids, and associated sound processors. In fiscal 2020, 49% of revenue came from the Americas, 35% from Europe, the Middle East, and Africa, and 16% from the Asia-Pacific segment.